|Day's Range||8.31 - 8.39|
|52 Week Range||7.32 - 8.99|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The week's action suggests other dealmakers may be thinking the same thing as Pfizer CEO Ian Read.
Predictions that M&A would accelerate any day now might have started to come true.
The fall in commodity prices (DBC) (BCX) and political turmoil in Brazil have led to a contraction in the economy.